Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis

Giovanni Palladini; Stefan O. Schönland; Vaishali Sanchorawala; Shaji Kumar; Ashutosh Wechalekar; Ute Hegenbart; Paolo Milani; Yukio Ando; Per Westermark; Angela Dispenzieri; Giampaolo Merlini

doi:10.1080/13506129.2020.1868810

Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis

Giovanni Palladini, Stefan O. Schönland, Vaishali Sanchorawala, Shaji Kumar, Ashutosh Wechalekar, Ute Hegenbart, Paolo Milani, Yukio Ando, Per Westermark, Angela Dispenzieri, Giampaolo Merlini

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Journal	Amyloid
DOIs	https://doi.org/10.1080/13506129.2020.1868810
Publication status	Accepted/In press - 2020

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1080/13506129.2020.1868810

Cite this

Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis. / Palladini, Giovanni; Schönland, Stefan O.; Sanchorawala, Vaishali; Kumar, Shaji; Wechalekar, Ashutosh; Hegenbart, Ute; Milani, Paolo; Ando, Yukio; Westermark, Per; Dispenzieri, Angela; Merlini, Giampaolo.

In: Amyloid, 2020.

Research output: Contribution to journal › Editorial › peer-review

@article{d91f01eb91c645d19d0969d42b2ef4d9,

title = "Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis",

author = "Giovanni Palladini and Sch{\"o}nland, {Stefan O.} and Vaishali Sanchorawala and Shaji Kumar and Ashutosh Wechalekar and Ute Hegenbart and Paolo Milani and Yukio Ando and Per Westermark and Angela Dispenzieri and Giampaolo Merlini",

note = "Funding Information: PW: Advisory board for, and research grants for the institution from Alnylam and Pfizer. Funding Information: AD: Advisory board for Janssen. Research funding from Pfizer, Alnylam, Celgene, Takeda. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2020",

doi = "10.1080/13506129.2020.1868810",

language = "English",

journal = "Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis",

issn = "1350-6129",

publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis

AU - Palladini, Giovanni

AU - Schönland, Stefan O.

AU - Sanchorawala, Vaishali

AU - Kumar, Shaji

AU - Wechalekar, Ashutosh

AU - Hegenbart, Ute

AU - Milani, Paolo

AU - Ando, Yukio

AU - Westermark, Per

AU - Dispenzieri, Angela

AU - Merlini, Giampaolo

N1 - Funding Information: PW: Advisory board for, and research grants for the institution from Alnylam and Pfizer. Funding Information: AD: Advisory board for Janssen. Research funding from Pfizer, Alnylam, Celgene, Takeda. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2020

Y1 - 2020

UR - http://www.scopus.com/inward/record.url?scp=85099240083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85099240083&partnerID=8YFLogxK

U2 - 10.1080/13506129.2020.1868810

DO - 10.1080/13506129.2020.1868810

M3 - Editorial

AN - SCOPUS:85099240083

JO - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

JF - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

SN - 1350-6129

ER -

Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this